Patents by Inventor Michael Patane

Michael Patane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POSITIVELY-CHARGED POLY (D,L-LACTIDE-CO-GLYCOLIDE) NANOPARTICLES AND FABRICATION METHODS OF THE SAME
    Publication number: 20120177741
    Abstract: The present technology provides compositions with positively-charged poly(d,l-lactide-co-glycolide) nanoparticles capable of releasing a bioactive substance in a body tissue for extended periods of time, as well as methods for manufacture of the same and methods for prophylactic and therapeutic treatment of a subject in need thereof.
    Type: Application
    Filed: September 29, 2010
    Publication date: July 12, 2012
    Applicant: EYEGATE PHARMACEUTICALS, INC.
    Inventors: Peyman Moslemy, Hong Wang, Michael Patane
  • Organic compounds and their uses
    Patent number: 8211932
    Abstract: The present application describes organic compounds of the Formula I that are useful for the treatment, prevention and/or amelioration of human diseases.
    Type: Grant
    Filed: September 10, 2010
    Date of Patent: July 3, 2012
    Assignee: Novartis AG
    Inventors: Michael Patane, Prakash Raman, David Thomas Parker, Jiping Fu, Branko Radetich, Mohindra Seepersaud, Aregahegn Yifru, Rui Zheng, Trixi Brandl, Francois Lenoir, Pascal Rigollier, Oliver Simic
  • Enhancing enzyme production
    Patent number: 7971389
    Abstract: The invention relates to a process for increasing the amount of enzymes in a grain by germinating the grain in conditions in which the grain is wounded. The invention also relates to hydrolases obtainable from grains for use in food processing and manufacturing industries, to the germination of grains such as barley and to isolation of enzymes from grains.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: July 5, 2011
    Assignees: Protech Research Pty Ltd., Emu AG
    Inventors: Michael Patane, Mitchell Parker, Akshat Talwalkar, Bernard Parker
  • Lactam compounds useful as protein kinase inhibitors
    Patent number: 7935694
    Abstract: The present invention provides novel compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
    Type: Grant
    Filed: September 4, 2008
    Date of Patent: May 3, 2011
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Christopher Blackburn, Christopher F. Claiborne, Courtney A. Cullis, Natalie A. Dales, Michael Patane, Matthew Stirling, Omar Stradella, Gabriel S. Weatherhead
  • LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS
    Publication number: 20110039820
    Abstract: The present invention provides novel compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
    Type: Application
    Filed: October 13, 2010
    Publication date: February 17, 2011
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Christopher Blackburn, Christopher F. Claiborne, Courtney A. Cullis, Natalie A. Dales, Michael Patane, Matthew Stirling, Omar Stradella, Gabriel S. Weatherhead
  • ORGANIC COMPOUNDS AND THEIR USES
    Publication number: 20100331243
    Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
    Type: Application
    Filed: September 10, 2010
    Publication date: December 30, 2010
    Inventors: Trixi Brandl, Jiping Fu, Francois Lenoir, David Thomas Parker, Michael Patane, Branko Radetich, Prakash Raman, Pascal Rigollier, Mohindra Seepersaud, Oliver Simic, Aregahegn Yifru, Rui Zheng
  • Organic compounds and their uses
    Patent number: 7825152
    Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
    Type: Grant
    Filed: April 9, 2007
    Date of Patent: November 2, 2010
    Assignee: Novartis AG
    Inventors: Trixi Brandl, Jiping Fu, Francois Lenoir, David Thomas Parker, Michael Patane, Branko Radetich, Prakash Raman, Pascal Rigollier, Mohindra Seepersaud, Oliver Simic, Aregahegn Yifru, Rui Zheng
  • AMINOTHIAZOLES AND THEIR USES
    Publication number: 20100267757
    Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases.
    Type: Application
    Filed: July 1, 2010
    Publication date: October 21, 2010
    Inventors: Matthew J. LaMarche, Simon Bushell, Michael A. Patane, Lewis Whitehead
  • Transfer of Molecules
    Publication number: 20100240129
    Abstract: The invention relates to liposomes, particularly, but not exclusively, to liposomes for introducing a molecule into a cell, and to processes for making and using liposomes.
    Type: Application
    Filed: June 1, 2010
    Publication date: September 23, 2010
    Inventor: Michael Patane
  • Modulators of melanocortin receptor
    Patent number: 7790719
    Abstract: This invention provides compounds and methods for treating melanocortin receptor associated disorders, such as weight loss disorders including cachexia resulting from cancer and other chronic illnesses. The compounds are represented by formula I: wherein X is oxygen or sulfur; G is G1 or G2: L1, L2, L3 and Q are linker groups, and Rings A, B and C, and R1-R14 are described in the specification. The compounds are antagonists of melanocortin receptors.
    Type: Grant
    Filed: July 26, 2007
    Date of Patent: September 7, 2010
    Assignee: Ore Pharmaceuticals, Inc.
    Inventors: Tricia J. Vos, Michael Patane, Michael E. Solomon, Christopher Blackburn, Mihaela D. Danca
  • ORGANIC COMPOUNDS AND THEIR USES
    Publication number: 20100204159
    Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
    Type: Application
    Filed: September 11, 2007
    Publication date: August 12, 2010
    Inventors: Trixl Brandl, Sylvain Cottens, Claus Ehrhardt, Jiping Fu, Subramanian Karur, David Thomas Parker, Michael A. Patane, Prakash Raman, Stefan Andreas Randl, Pascal Rigollier, Mohindra Seepersaud, Oliver Simic
  • Extracting And Purifying Lipoxygenase
    Publication number: 20100144009
    Abstract: The present invention relates to the extraction and purification of lipoxygenase from plant matter, including soy beans. A process for purifying lipoxygenase from plant matter is provided.
    Type: Application
    Filed: December 20, 2007
    Publication date: June 10, 2010
    Inventors: Michael Patane, Akshat Talwalkar
  • DELIVERY OF CORTICOSTEROIDS THROUGH IONTOPHORESIS
    Publication number: 20090306579
    Abstract: Disclosed herein are formulations of dexamethasone or a prodrug thereof suitable for delivery by ocular iontophoresis and methods of use thereof.
    Type: Application
    Filed: February 24, 2009
    Publication date: December 10, 2009
    Inventors: Mike Jaffe, Gary Cook, Perry Calias, Michael A. Patane
  • Enhancing enzyme production
    Publication number: 20090217579
    Abstract: The invention relates to a process for increasing the amount of enzymes in a grain by germinating the grain in conditions in which the grain is wounded. The invention also relates to hydrolases obtainable from grains for use in food processing and manufacturing industries, to the germination of grains such as barley and to isolation of enzymes from grains.
    Type: Application
    Filed: August 25, 2006
    Publication date: September 3, 2009
    Inventors: Michael Patane, Mitchell Parker, Akshat Talwalkar, Bernard Parker
  • Extracting and purifying beta 1,4-xylanase
    Publication number: 20090137022
    Abstract: The invention relates to extracting and purifying an enzyme from a cell, particularly, but not exclusively, to extracting and purifying a ?1,4-xylanase.
    Type: Application
    Filed: August 25, 2006
    Publication date: May 28, 2009
    Applicant: PROTECH RESEARCH PTY LTD
    Inventors: Michael Patane, Mitchell Parker, Akshat Talwalkar
  • Extracting and purifying limit dextrinases
    Publication number: 20090123987
    Abstract: The invention relates to improved methods for extracting and purifying limit dextrinase enzymes from cells, in particular plant cells. The process of the invention includes heating a cell homogenate at 4O° C., in the presence of divalent cations thus increasing the specific activity of the limit dextrinase.
    Type: Application
    Filed: August 25, 2006
    Publication date: May 14, 2009
    Inventors: Michael Patane, Mitchell Parker, Akshat Talwalkar
  • Lactam compounds useful as protein kinase inhibitors
    Publication number: 20090105213
    Abstract: The present invention provides novel compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
    Type: Application
    Filed: September 4, 2008
    Publication date: April 23, 2009
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Christopher Blackburn, Christopher F. Claiborne, Courtney A. Cullis, Natalie A. Dales, Michael Patane, Matthew Stirling, Omar Stradella, Gabriel S. Weatherhead
  • Lactam compounds useful as protein kinase inhibitors
    Patent number: 7459448
    Abstract: The present invention provides novel compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
    Type: Grant
    Filed: October 3, 2005
    Date of Patent: December 2, 2008
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Christopher Blackburn, Christopher F. Claiborne, Courtney A. Cullis, Natalie A. Dales, Michael Patane, Matthew Stirling, Omar Stradella, Gabriel S. Weatherhead
  • Melanocortin-4 receptor binding compounds and methods of use thereof
    Publication number: 20080269217
    Abstract: Provided are MC4-R binding compounds of the formula XVII: wherein L2 is a linker group, and P1, P2, P3, P4, Z1, Z2, Z3, Z4, Z5, t, s, and R are as described in the specification. Methods of using the compounds to treat MC4-R associated disorders, such as disorders associated with weight loss, are also provided.
    Type: Application
    Filed: May 1, 2008
    Publication date: October 30, 2008
    Applicant: Ore Pharmaceuticals, Inc.
    Inventors: Tricia J. Vos, Michael E. Solomon, Christopher F. Claiborne, Martin P. Maguire, Mingshi Dai, Michael Patane, Thoma H. Marsilje
  • EFTU INHIBITORS OR AMINOTHIAZOLES AND THEIR USES
    Publication number: 20080221142
    Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases.
    Type: Application
    Filed: May 30, 2007
    Publication date: September 11, 2008
    Inventors: Matthew J. LaMarche, Simon Bushell, Michael A. Patane, Lewis Whitehead